Sexually transmitted infections (STIs) have a profound impact on sexual and reproductive health worldwide.
Across the globe there is a significant need for improved sexual health awareness and high-quality testing. Access to testing in low- and middle-income countries remains a challenge, while higher income areas need to improve surveillance strategies to address challenges, such as drug-resistant pathogens.
Roche’s high-quality automated systems and innovative assays support accurate diagnoses, guide treatment, and help with the long-term management of patients. From the way samples are collected to the way results are delivered, our advanced diagnostic solutions cater to the unique challenges of each disease. With the right routine testing, more people around the world can enjoy safer and healthier intimate experiences.